ada guidelines glp-1 New EASD-ADA consensus on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia Frontiers | Mechanisms of action

The study reported that 13.3% (558) of the respondents had COVID-19 symptoms lasting for 28 days, with 4.5% (189) having experienced symptoms for 56 days and 2.6% (108) for a duration of more than 84 days

SKINWORKOUThyaluronic acid serums are clinical grade, pure, and sterile

Bain S, Druyts E, Balijepalli C, Baxter CA, Currie CJ, Das R, et al

G., Lopez, E., Krishnan, K., & Bittner, E

Lorena Pacheco reports the following support: K01HL169414 from the National Heart, Lung, and Blood Institute

Key trial results: The mechanism is dual: afamelanotide increases eumelanin density in the skin (absorbing UV photons before they reach vulnerable cellular targets) while simultaneously activating anti-inflammatory pathways that reduce the phototoxic cascade